Barclays’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.33M | Sell |
|
|||||
|
2025
Q2 | $2.62M | Buy |
|
|||||
|
2025
Q1 | $1.28M | Sell |
|
|||||
|
2024
Q4 | $1.6M | Sell |
|
|||||
|
2024
Q3 | $882K | Buy |
|
|||||
|
2024
Q2 | $385K | Sell |
|
|||||
|
2024
Q1 | $572K | Sell |
|
|||||
|
2023
Q4 | $1.96M | Buy |
|
|||||
|
2023
Q3 | $1.05M | Sell |
|
|||||
|
2023
Q2 | $1.56M | Buy |
|
|||||
|
2023
Q1 | $1.63M | Buy |
|
|||||
|
2022
Q4 | $93K | Sell |
|
|||||
|
2022
Q3 | $1.95M | Buy |
|
|||||
|
2022
Q2 | $100K | Sell |
|
|||||
|
2022
Q1 | $1.48M | Sell |
|
|||||
|
2021
Q4 | $3.33M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $292K | Sell |
|
|||||
|
2021
Q1 | $1.3M | Buy |
|
|||||
|
2020
Q4 | $396K | Sell |
|
|||||
|
2020
Q3 | $369K | Sell |
|
|||||
|
2020
Q2 | $529K | Buy |
|
|||||
|
2020
Q1 | $214K | Buy |
|
|||||
|
2019
Q4 | $111K | Buy |
|
|||||
|
2019
Q3 | $67K | Sell |
|
|||||
|
2019
Q2 | $93K | Sell |
|
|||||
|
2019
Q1 | $358K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $149K | Buy |
|
|||||
|
2018
Q1 | $22K | Sell |
|
|||||
|
2017
Q4 | $71K | Sell |
|
|||||
|
2017
Q3 | $96K | Buy |
|
|||||
|
2017
Q2 | $10K | Sell |
|
|||||
|
2017
Q1 | $81K | Buy |
|
|||||
|
2016
Q4 | $2K | Buy |
|
|||||
|
2016
Q3 | $1K | Buy |
|